AAV9 intracerebroventricular gene therapy improves lifespan and normalises long-term locomotor behaviour in a mouse model of Niemann-Pick type C1 disease

被引：0
|
作者：
Hughes, Michael [1 ]
Smith, Dave [2 ]
Morris, Lauren [2 ]
Fletcher, Claire [2 ]
Colaco, Allie [2 ]
Huebecker, Mylene [2 ]
Massaro, Giulia [1 ]
Tordo, Julie [3 ]
Palomar, Nuria [3 ]
Henckaerts, Els [3 ]
Waddington, Simon [4 ]
Platt, Fran [2 ]
Rahim, Ahad [1 ]
机构：
[1] UCL Sch Pharm, London, England
[2] Univ Oxford, Oxford, England
[3] Kings Coll London, London, England
[4] UCL Inst Womens Hlth, London, England
来源：
HUMAN GENE THERAPY | 2018年 / 29卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PO09
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 50 条
  • [31] 1H magnetic resonance spectroscopy of neurodegeneration in a mouse model of niemann-pick type C1 disease
    Totenhagen, John W.
    Yoshimaru, Eriko S.
    Erickson, Robert P.
    Trouard, Theodore P.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2013, 37 (05) : 1195 - 1201
  • [32] Cerebellar Long-term Depression is Deficient in Niemann-Pick Type C Disease Mice
    Sun, Cheng-Long
    Su, Li-Da
    Li, Qiong
    Wang, Xin-Xin
    Shen, Ying
    CEREBELLUM, 2011, 10 (01): : 88 - 95
  • [33] Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease
    Marshall, Craig A.
    Borbon, Ivan A.
    Erickson, Robert P.
    JOURNAL OF APPLIED GENETICS, 2017, 58 (01) : 99 - 102
  • [34] Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease
    Craig A. Marshall
    Ivan A. Borbon
    Robert P. Erickson
    Journal of Applied Genetics, 2017, 58 : 99 - 102
  • [35] Characterization of a Novel AAV Gene Replacement Therapy, VY-NPC101, In Vitro and In Vivo for the Treatment of Niemann-Pick Disease Type C1
    Knoll, Elisabeth R.
    Tocci, Jenna
    Ezell, Brian
    Liu, Eric
    Sayed-Zahid, Ambreen
    Li, Mingwei
    Patzke, Holger
    Carter, Todd
    Bales, Kelly
    Brown, Jeffrey
    Yonutas, Heather
    MOLECULAR THERAPY, 2022, 30 (04) : 436 - 436
  • [36] VY-NPC101: in vitro and in vivo validation of a novel AAV gene replacement therapy to treat Niemann-Pick disease Type C1
    Knoll, E.
    Ezell, B.
    Liu, E.
    Sayed-Zahid, A.
    Li, M.
    Patzke, H.
    Tocci, J.
    Brown, J.
    Bales, K.
    Yonutas, H. M.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A50 - A50
  • [37] Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease
    Alvarez, Alejandra R.
    Klein, Andres
    Castro, Juan
    Cancino, Gonzalo I.
    Amigo, Julio
    Mosqueira, Matias
    Vargas, Lina M.
    Yevenes, L. Fernanda
    Bronfman, Francisca C.
    Zanlungo, Silvana
    FASEB JOURNAL, 2008, 22 (10): : 3617 - 3627
  • [38] Promoter Evaluation of AAV Gene Therapy in the Central Nervous System for Feline Niemann-Pick Type C Disease
    Gurda, Brittney L.
    Swain, Gary
    Bagel, Jessica H.
    Prociuk, Maria
    Gray, Steven J.
    Fitzgerald, Caitlin
    O'Donnell, Patricia
    Vite, Charles H.
    MOLECULAR THERAPY, 2016, 24 : S242 - S242
  • [39] Enhanced Efficacy of Gene Therapy Treatment for Niemann-Pick C1 Disease Using a Novel Serotype, AAV-PHP.B
    Gu, Tansy
    Davidson, Cristin
    Gibson, Alana
    Chandler, Randy
    Beadle, Keith
    Deverman, Ben
    Ory, Daniel S.
    Gradinaru, Viviana
    Pavan, William J.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2018, 26 (05) : 404 - 404
  • [40] Comparative Hippocampal Proteome and Phosphoproteome in a Niemann-Pick, Type C1 Mouse Model Reveal Insights into Disease Mechanisms
    Nguyen, Thu T. A.
    Mohanty, Varshasnata
    Yan, Ying
    Francis, Kevin R.
    Cologna, Stephanie M.
    JOURNAL OF PROTEOME RESEARCH, 2023, 23 (01) : 84 - 94
12345